Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice.
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of MACUGEN in patients suffering from neovascular age-related macular
degeneration in routine clinical practice at least as good as demonstrated in randomized
multicenter clinical trials.